2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model.
Saved in:
| Title: | 2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model. |
|---|---|
| Authors: | Salah, S.1 (AUTHOR), Kobayashi, T.2 (AUTHOR), Ito, K.2 (AUTHOR), Kita, Y.2 (AUTHOR), Horani, M.3 (AUTHOR), Alshangiti, A.1 (AUTHOR), Abu Hijlih, R.4 (AUTHOR), Sammour, M.5 (AUTHOR), Abuhijla, F.4 (AUTHOR), Al-Rabi, K.5 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1159-S1159. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.2094 |
